Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

52.41
+0.45000.87%
Post-market: 52.420.0100+0.02%19:59 EDT
Volume:2.40M
Turnover:125.62M
Market Cap:106.01B
PE:16.76
High:52.57
Open:51.35
Low:51.35
Close:51.96
52wk High:61.70
52wk Low:38.63
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.71
T/O Rate:0.12%
Dividend:1.77
Dividend Rate:3.38%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.40
PE(LYR):14.03

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Jul 17

GlaxoSmithKline (GSK) Gets a Buy from Jefferies

TIPRANKS
·
Jul 17

GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment

Dow Jones
·
Jul 17

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

TIPRANKS
·
Jul 17

GSK Will Likely Need to Book Write-down on Cough Drug Failure

Dow Jones
·
Jul 17

GSK Stops Camlipixant Program in Refractory Chronic Cough After Phase 3 Data

MT Newswires Live
·
Jul 17

Movement Alert|GSK Falls 4.42% in Pre-Market Trading, Trading at $50.41

Market Focus
·
Jul 17

GSK Halts Camlipixant Development in Chronic Cough After Mixed Phase III Results

TIPRANKS
·
Jul 17

GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing

TIPRANKS
·
Jul 17

GSK Rises Thursday, Outperforms Market

Dow Jones
·
Jul 17

GSK executives boost holdings via dividend-funded ADS purchases

TIPRANKS
·
Jul 16

GSK’s New Phase 3 Ovarian Cancer Trial Puts Mo-Rez in the First-Line Spotlight

TIPRANKS
·
Jul 16

Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?

Simply Wall St.
·
Jul 15

GSK Completes $10.6 Billion Acquisition of Nuvalent

MT Newswires Live
·
Jul 15

GSK Slides Tuesday, Underperforms Market

Dow Jones
·
Jul 15

GSK Executives Acquire Shares Under Routine Reward Plan

TIPRANKS
·
Jul 13

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 13

GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients

TIPRANKS
·
Jul 13

J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 13

Guggenheim Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 10